000 04488nam a22004095i 4500
999 _c392494
_d392494
001 392494
003 ES-MaUEC
005 20231005115951.0
006 a|||| o|||| 00| 0
007 cr nn 008mamaa
008 100301s2003 xxu| o |||| 0|eng d
020 _a9781592593729
024 7 _a10.1385/1592593720
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC280.P7
_b2003 EB
245 0 0 _aProstate Cancer Methods and Protocols
_cedited by Pamela J. Russell, Paul Jackson, Elizabeth A. Kingsley
250 _a1st edition 2003
264 1 _aTotowa, NJ
_bHumana Press
_c2003
300 _a1 recurso en línea (XII, 403 páginas)
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Medicine
_x1940-6037
_v81
505 0 _aEpidemiological Investigation of Prostate Cancer -- Human Prostate Cancer Cell Lines -- Growth of Prostatic Epithelial and Stromal Cells In Vitro -- Prostate Epithelial Stem Cell Isolation and Culture -- Generation of Immortal Human Prostate Cell Lines for the Study of Prostate Cancer -- Spheroids of Prostate Tumor Cell Lines -- Animal Models of Prostate Cancer -- Transgenic Mouse Models for Prostate Cancer -- In Vivo Models of Human Prostate Cancer Bone Metastasis -- Effects of Fixation on Tissues -- Background, Methods, and Protocols for the Histopathological Diagnosis of Prostate Carcinoma -- Realizing the Potential of Ejaculate/Seminal Fluid in Detecting and Predicting Natural History -- Bisulfite Methylation Analysis of Tumor Suppressor Genes in Prostate Cancer from Fresh and Archival Tissue Samples -- Production and Characterization of Antipeptide Kallikrein 4 Antibodies -- The Androgen Receptor CAG Repeat and Prostate Cancer Risk -- Studies on Androgen Receptor Mutations and Amplification in Human Prostate Cancer -- Proteomics in the Analysis of Prostate Cancer -- Application of Gene Microarrays in the Study of Prostate Cancer -- Enhancer Trap Method Using a Green Fluorescent Protein Reporter Plasmid for Cloning Tissue-Specific Enhancers Active in Prostate Cells -- Targeted Alpha Therapy of Prostate Cancer -- Phenotypic and Functional Differences of Dendritic Cells Generated Under Different In Vitro Conditions -- Flavonoid Compounds in the Prevention and Treatment of Prostate Cancer.
520 _aWith the prostate as the second leading site of cancer among males in Western society, the need to know why certain prostate cancers remain localized while others become aggressive and metastasize has become critical for the care of patients. In Prostate Cancer Methods and Protocols, leading investigators present basic and advanced molecular methods that reveal those markers essential for more accurate diagnoses of specific diseases, and in developing new treatment strategies. The techniques range from in vitro methods to in vivo models of prostate cancer. New methods for the accurate diagnosis of prostate cancer are also offered, including histological assessment, studies of cells in semen, and methylation analysis of the GSTpi, a potential prostate cancer-specific marker. Additional approaches, including proteome and microarray analyses, address such issues as assessing changes in the androgen receptor and studying the enzymes secreted by prostate cancer cells. New strategies for the treatment of refractory disease cover the role of flavonoids, targeted alpha therapy, methods for implementing immune therapy, and prostate-specific gene therapy. Each method is described in step-by-step detail to ensure successful results. Comprehensive and cutting-edge, Prostate Cancer Methods and Protocols provides access to the many powerful tools needed by scientists engaged in prostate cancer research today, as well as up-to-date reviews on several key aspects of the disease.
988 _aSpringer_Protocols_2003
650 7 _2embne
_9182337
_aPróstata
_xCáncer
650 7 _2embne
_9138565
_aUrología
776 0 8 _iPrinted edition:
_z9781489938503
776 0 8 _iPrinted edition:
_z9780896039780
776 0 8 _iPrinted edition:
_z9781489938497
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1385/1592593720
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b10/2023
_dz
_eIG
_zSI